Text Size

Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders (UPQUAL)

This study has been completed.
Sponsor:
Collaborator:
Agency for Healthcare Research and Quality (AHRQ)
Information provided by (Responsible Party):
Kenzie Cameron, Northwestern University
ClinicalTrials.gov Identifier:
NCT00793455
First received: November 17, 2008
Last updated: October 24, 2011
Last verified: October 2011
History of Changes
  Purpose

The purpose of this study is to evaluate whether patient outreach is effective at increasing compliance with preventive screenings ordered by their physician. We hypothesize that educational outreach may increase completion rates.


Condition Intervention
Colorectal Cancer Screening
Prevention & Control
 Behavioral: Educational outreach

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Health Services Research
Official Title: Using Precision Performance Measurement To Conduct Focused Quality Improvement. Sub-Study 1.

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Northwestern University:

Primary Outcome Measures:
  • Colorectal Cancer Screening Completion. [ Time Frame: 3 months post randomization ] [ Designated as safety issue: No ]

    We reviewed electronic health records of participants 3 months post randomization to ascertain outcome. We looked for one or both of the following (1) note in free text MD note documenting receipt of one form of colorectal cancer (CRC) screening during study period (2)lab results from fecal occult blood test, sigmoidoscopy, or colonoscopy.

    Participants were categorized as completing CRC screening if there was a lab result or physician note located in chart during study period. If no note or lab result was found in chart, then the participant was categorized as not completing CRC screening.



Secondary Outcome Measures:
  • Colorectal Cancer Screening Completion [ Time Frame: 6 months post randomization ] [ Designated as safety issue: No ]

    We reviewed electronic health records of participants 6 months post randomization to ascertain outcome. We looked for one or both of the following (1) note in free text MD note documenting receipt of one form of colorectal cancer (CRC) screening during study period (2)lab results from fecal occult blood test, sigmoidoscopy, or colonoscopy.

    Participants were categorized as completing CRC screening if there was a lab result or physician note located in chart during study period. If no note or lab result was found in chart, then the participant was categorized as not completing CRC screening.



Enrollment: 628
Study Start Date: October 2008
Study Completion Date: November 2009
Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Intervention Group
Received Educational Outreach
 Behavioral: Educational outreach
Participants will get a letter from their physician that explains that their records show the test has not been completed. The letter will be mailed along with an educational brochure and a DVD about colorectal cancer and colorectal cancer screening.
No Intervention: Usual Care Control Group
Participants in this arm will receive normal care until outcome assessment is performed at 6 months following the placement of the order for the preventive service. They will be sent a letter reminding them to obtain the ordered preventive service test.

Detailed Description:

We designed an intervention to focus on patients who have received and accepted a referral for colonoscopy, yet have exhibited some barriers to screening as demonstrated by a lack of screening completion. We conducted a randomized controlled trial to assess the effects of a multicomponent intervention (patient reminder, print and multimedia materials) on colorectal screening completion among this target population.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient's physician has ordered a preventive screening test
  • Patient has not completed this test in 3 months
  • Patient of Northwestern Medical Faculty Foundation General Internal Medicine Clinic.

Exclusion Criteria:

  • Patient has been given a more recent order for the same screening test.
  • Patient has significant life stress as noted in the Electronic Health Record (EHR)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00793455

Locations
United States, Illinois
Northwestern Medical Faculty Foundation General Internal Medicine Clinic
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
Agency for Healthcare Research and Quality (AHRQ)
Investigators
Principal Investigator: Kenzie A Cameron, PhD, MPH Northwestern University
  More Information

Publications:

Responsible Party: Kenzie Cameron, Research Associate Professor, Northwestern University
ClinicalTrials.gov Identifier: NCT00793455     History of Changes
Other Study ID Numbers: 1R18HS17163-01
Study First Received: November 17, 2008
Results First Received: September 1, 2011
Last Updated: October 24, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Northwestern University:
education
preventive service
screening

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
 Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on May 16, 2013